Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 30, 2018

SELL
$13.65 - $18.7 $495,194 - $678,398
-36,278 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$14.85 - $24.3 $373,685 - $611,485
25,164 Added 226.42%
36,278 $577,000
Q3 2017

Nov 15, 2017

BUY
$15.5 - $19.15 $172,267 - $212,833
11,114
11,114 $198,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.08B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cambria Investment Management, L.P. Portfolio

Follow Cambria Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Cambria Investment Management, L.P. with notifications on news.